We report the case of a 77-year-old man who presented to our hospital with
cecal cancer, lung
metastasis, and liver
metastasis in January 2013. After four courses of modified infusional intravenous
fluorouracil and levofolinate with
oxaliplatin (mFOLFOX 6) +
bevacizumab, there was no new metastatic lesion and lung
metastasis reduction was observed. Ileocecal resection was performed in May, left lower lung lobectomy in August, and extended right posterior
segmentectomy + S8 partial liver resection was performed in December. The
tumor marker declined initially;thereafter, it gradually increased. Computed tomography (CT) performed in April 2014 revealed right inguinal mass around the mesh-plug
prosthesis. A positron emission tomography-CT (PET-CT) also revealed a high
2-fluoro-2-deoxy-D-glucose (FDG) uptake at the same site. Right inguinal
tumor resection was performed in July.
Cancer tissues were confirmed by performing intraoperative rapid pathological diagnosis, and R0 resection could be achieved. Previous studies have reported malignant
tumor metastases to the mesh-plug
prosthesis, and this was believed to one of the sites that
cancer cells can easily engraft. In particular, in patients with a history of advanced malignant
tumors, if mass formation around the artifact insertion site is observed, the possibility of peritoneal
metastasis should be considered. J. Med. Invest. 65:142-146, February, 2018.